Monopar’s uPA Antibody Fragment Radiotracer Shows Potential for PET Imaging of Breast Cancer in Preclinical Study
Go back to Monopar’s uPA Antibody Fragment Radiotracer Shows Potential for PET Imaging of Breast Cancer in Preclinical Study(NASDAQ: MNPR) | Delayed: 0.68 +0.02 (3.03%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.66 | 52 Week High | $ | |||
Open | $0.70 | 52 Week Low | $ | |||
Day High | $0.72 | P/E | N/A | |||
Day Low | $0.66 | EPS | $ | |||
Volume | 77,544 |